Genetic Inactivation of ADAMTS15 Metalloprotease in Human Colorectal Cancer
Open Access
- 1 June 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (11) , 4926-4934
- https://doi.org/10.1158/0008-5472.can-08-4155
Abstract
Matrix metalloproteinases have been traditionally linked to cancer dissemination through their ability to degrade most extracellular matrix components, thus facilitating invasion and metastasis of tumor cells. However, recent functional studies have revealed that some metalloproteases, including several members of the ADAMTS family, also exhibit tumor suppressor properties. In particular, ADAMTS1, ADAMTS9, and ADAMTS18 have been found to be epigenetically silenced in malignant tumors of different sources, suggesting that they may function as tumor suppressor genes. Herein, we show that ADAMTS15 is genetically inactivated in colon cancer. We have performed a mutational analysis of the ADAMTS15 gene in human colorectal carcinomas, with the finding of four mutations in 50 primary tumors and 6 colorectal cancer cell lines. Moreover, functional in vitro and in vivo studies using HCT-116 and SW-620 colorectal cancer cells and severe combined immunodeficient mice have revealed that ADAMTS15 restrains tumor growth and invasion. Furthermore, the presence of ADAMTS15 in human colorectal cancer samples showed a negative correlation with the histopathologic differentiation grade of the corresponding tumors. Collectively, these results provide evidence that extracellular proteases, including ADAMTS15, may be targets of inactivating mutations in human cancer and further validate the concept that secreted metalloproteases may show tumor suppressor properties. [Cancer Res 2009;69(11):4926–34]All Related Versions
This publication has 33 references indexed in Scilit:
- Proteases: Multifunctional Enzymes in Life and DiseaseJournal of Biological Chemistry, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomasOncogene, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Xenopus ADAMTS1 negatively modulates FGF signaling independent of its metalloprotease activityDevelopmental Biology, 2006
- Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumoursBritish Journal of Cancer, 2006
- ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinomaInternational Journal of Cancer, 2005
- Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectivelyOncogene, 2005
- The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potentialBiochemical and Biophysical Research Communications, 2004
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989